- Non invasive, quick and easy to perform
- Shows patient’s response to treatment, enabling the correct prescription of medication
- Shows patient compliance
- Aids in identifying patients who do/do not require ongoing treatment
- Shown to be superior to the majority of conventional tests of lung function, such as peak flow recording and spirometry
NObreath FENO Monitor by Bedfont Scientific
Measure Breath Nitric Oxide for Airway Inflammation with NObreath FENO Monitor
Airway inflammation is a central process in asthma and other lung diseases. Being able to measure this inflammation and monitor the patient’s reaction to medication is regarded as a gold standard in the management of respiratory diseases. It is increasingly recognised that the measurement of FENO in particular constitutes a novel way to monitor separate aspects of diseases. These include asthma, COPD and interstitial lung diseases, that are not assessed by other means, such as lung function. FENO measurements to evaluate airway inflammation in asthma represents a significant advance in respiratory medicine, but until now this has been an expensive test to deliver in everyday practice.
NOW recommended in the NICE Guidelines for Asthma Management
The Nice Guidelines recommends using Bedfont’s NObreath monitor to help guide the diagnosis and management of asthma in both adults and children. Please download documents below for detailed recommendations.